Annual Retained Earnings
-$725.91 M
-$237.73 M-48.70%
31 December 2023
Summary:
Viridian Therapeutics annual retained earnings is currently -$725.91 million, with the most recent change of -$237.73 million (-48.70%) on 31 December 2023. During the last 3 years, it has fallen by -$367.61 million (-102.60%). VRDN annual retained earnings is now -10832.35% below its all-time high of -$6.64 million, reached on 31 December 2014.VRDN Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Retained Earnings
-$916.13 M
-$76.69 M-9.14%
30 September 2024
Summary:
Viridian Therapeutics quarterly retained earnings is currently -$916.13 million, with the most recent change of -$76.69 million (-9.14%) on 30 September 2024. Over the past year, it has dropped by -$190.22 million (-26.20%). VRDN quarterly retained earnings is now -13697.17% below its all-time high of -$6.64 million, reached on 31 December 2014.VRDN Quarterly Retained Earnings Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
VRDN Retained Earnings Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | - | -26.2% |
| 3 y3 years | -102.6% | -155.7% |
| 5 y5 years | -331.6% | -444.8% |
VRDN Retained Earnings High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -102.6% | at low | -155.7% | at low |
| 5 y | 5 years | -331.6% | at low | -444.8% | at low |
| alltime | all time | <-9999.0% | at low | <-9999.0% | at low |
Viridian Therapeutics Retained Earnings History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | -$916.13 M(+9.1%) |
| June 2024 | - | -$839.44 M(+8.4%) |
| Mar 2024 | - | -$774.45 M(+6.7%) |
| Dec 2023 | -$725.91 M(+48.7%) | -$725.91 M(+10.1%) |
| Sept 2023 | - | -$659.05 M(+7.8%) |
| June 2023 | - | -$611.39 M(+9.9%) |
| Mar 2023 | - | -$556.33 M(+14.0%) |
| Dec 2022 | -$488.17 M(+36.2%) | -$488.17 M(+10.3%) |
| Sept 2022 | - | -$442.39 M(+7.0%) |
| June 2022 | - | -$413.48 M(+7.7%) |
| Mar 2022 | - | -$383.99 M(+7.2%) |
| Dec 2021 | -$358.30 M(+28.5%) | -$358.30 M(+8.8%) |
| Sept 2021 | - | -$329.35 M(+4.5%) |
| June 2021 | - | -$315.31 M(+6.0%) |
| Mar 2021 | - | -$297.35 M(+6.6%) |
| Dec 2020 | -$278.89 M(+65.8%) | -$278.89 M(+48.2%) |
| Sept 2020 | - | -$188.15 M(+3.0%) |
| June 2020 | - | -$182.65 M(+3.7%) |
| Mar 2020 | - | -$176.22 M(+4.8%) |
| Dec 2019 | -$168.17 M | -$168.17 M(+6.4%) |
| Sept 2019 | - | -$158.05 M(+7.6%) |
| June 2019 | - | -$146.82 M(+6.4%) |
| Date | Annual | Quarterly |
|---|---|---|
| Mar 2019 | - | -$137.93 M(+9.2%) |
| Dec 2018 | -$126.30 M(+34.9%) | -$126.30 M(+8.9%) |
| Sept 2018 | - | -$115.98 M(+8.4%) |
| June 2018 | - | -$106.97 M(+8.9%) |
| Mar 2018 | - | -$98.25 M(+5.0%) |
| Dec 2017 | -$93.59 M(+205.4%) | -$93.59 M(+7.3%) |
| Sept 2017 | - | -$87.21 M(+7.2%) |
| June 2017 | - | -$81.37 M(+9.9%) |
| Mar 2017 | - | -$74.06 M(+141.7%) |
| Dec 2016 | -$30.64 M(+70.5%) | -$30.64 M(+22.2%) |
| Sept 2016 | - | -$25.07 M(+7.9%) |
| June 2016 | - | -$23.23 M(+12.1%) |
| Mar 2016 | - | -$20.73 M(+15.3%) |
| Dec 2015 | -$17.97 M(+170.6%) | -$17.97 M(+19.9%) |
| Sept 2015 | - | -$14.99 M(+26.6%) |
| June 2015 | - | -$11.84 M(+27.6%) |
| Mar 2015 | - | -$9.27 M(+39.7%) |
| Dec 2014 | -$6.64 M(-72.2%) | -$6.64 M(-78.9%) |
| Sept 2014 | - | -$31.52 M(+5.5%) |
| June 2014 | - | -$29.88 M(+12.4%) |
| Mar 2014 | - | -$26.59 M(+11.3%) |
| Dec 2013 | -$23.89 M(+11.4%) | -$23.89 M |
| Dec 2012 | -$21.44 M | - |
FAQ
- What is Viridian Therapeutics annual retained earnings?
- What is the all time high annual retained earnings for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly retained earnings?
- What is the all time high quarterly retained earnings for Viridian Therapeutics?
- What is Viridian Therapeutics quarterly retained earnings year-on-year change?
What is Viridian Therapeutics annual retained earnings?
The current annual retained earnings of VRDN is -$725.91 M
What is the all time high annual retained earnings for Viridian Therapeutics?
Viridian Therapeutics all-time high annual retained earnings is -$6.64 M
What is Viridian Therapeutics quarterly retained earnings?
The current quarterly retained earnings of VRDN is -$916.13 M
What is the all time high quarterly retained earnings for Viridian Therapeutics?
Viridian Therapeutics all-time high quarterly retained earnings is -$6.64 M
What is Viridian Therapeutics quarterly retained earnings year-on-year change?
Over the past year, VRDN quarterly retained earnings has changed by -$190.22 M (-26.20%)